Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Lung Neoplasms 15 Carcinoma, Non-Small-Cell Lung 4 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pulmonary Nodule Cm 1 Pulmonary Disease, Chronic Obstructive 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Lymphoma, AIDS-Related 1 Lung Diseases 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Laryngeal Neoplasms 1 Infections 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Graft vs Host Disease 1 Congenital Abnormalities 1 Carcinoma, Squamous Cell 1 Carcinoma, Bronchogenic 1

Interventions

pembrolizumab 180 Gemcitabine 168 Paclitaxel 150 Carboplatin 134 Bevacizumab 126 Cisplatin 113 Docetaxel 112 Cyclophosphamide 109 Exercise 97 Nivolumab 92 Fluorouracil 88 Capecitabine 85 Dexamethasone 81 Irinotecan 74 Radiotherapy 68 Oxaliplatin 68 Pemetrexed 66 Standard of Care 64 Leucovorin 63 Cetuximab 59 Sorafenib 53 Erlotinib Hydrochloride 53 Drug Therapy 53 Blood Specimen Collection 52 Doxorubicin 50 trametinib 47 atezolizumab 47 Ipilimumab 47 Albumin-Bound Paclitaxel 44 130-nm albumin-bound paclitaxel 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Bronchoscopy × Clear all

NCT00652769 2017-11-01

BOOST

University College London Hospitals

Phase 3 Completed

Carcinoma, Bronchogenic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡